205 related articles for article (PubMed ID: 26557666)
61. Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo.
Hu T; Li P; Luo Z; Chen X; Zhang J; Wang C; Chen P; Dong Z
Oncol Rep; 2016 Jan; 35(1):43-9. PubMed ID: 26530158
[TBL] [Abstract][Full Text] [Related]
62. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
Kozar K; Kaminski R; Legat M; Kopec M; Nowis D; Skierski JS; Koronkiewicz M; Jakóbisiak M; Golab J
Int J Oncol; 2004 May; 24(5):1149-57. PubMed ID: 15067336
[TBL] [Abstract][Full Text] [Related]
63. Hepatocellular carcinoma and chemotherapy: the role of p53.
Brito AF; Abrantes AM; Pinto-Costa C; Gomes AR; Mamede AC; Casalta-Lopes J; Gonçalves AC; Sarmento-Ribeiro AB; Tralhão JG; Botelho MF
Chemotherapy; 2012; 58(5):381-6. PubMed ID: 23257706
[TBL] [Abstract][Full Text] [Related]
64. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
65. Smh-3 induces G(2)/M arrest and apoptosis through calcium‑mediated endoplasmic reticulum stress and mitochondrial signaling in human hepatocellular carcinoma Hep3B cells.
Liu CY; Yang JS; Huang SM; Chiang JH; Chen MH; Huang LJ; Ha HY; Fushiya S; Kuo SC
Oncol Rep; 2013 Feb; 29(2):751-62. PubMed ID: 23233035
[TBL] [Abstract][Full Text] [Related]
66. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
[TBL] [Abstract][Full Text] [Related]
67. Effects of thonningianin A in natural foods on apoptosis and cell cycle arrest of HepG-2 human hepatocellular carcinoma cells.
Zhang TT; Yang L; Jiang JG
Food Funct; 2015 Aug; 6(8):2588-97. PubMed ID: 26119846
[TBL] [Abstract][Full Text] [Related]
68. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells.
Pinmai K; Chunlaratthanabhorn S; Ngamkitidechakul C; Soonthornchareon N; Hahnvajanawong C
World J Gastroenterol; 2008 Mar; 14(10):1491-7. PubMed ID: 18330936
[TBL] [Abstract][Full Text] [Related]
69. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells.
Pan YY; Xu SP; Jia XY; Xu HQ; Zhang Y; Rui LX; Wei W
Exp Oncol; 2007 Mar; 29(1):23-9. PubMed ID: 17431384
[TBL] [Abstract][Full Text] [Related]
70. JA, a new type of polyunsaturated fatty acid isolated from Juglans mandshurica Maxim, limits the survival and induces apoptosis of heptocarcinoma cells.
Gao XL; Lin H; Zhao W; Hou YQ; Bao YL; Song ZB; Sun LG; Tian SY; Liu B; Li YX
Apoptosis; 2016 Mar; 21(3):340-50. PubMed ID: 26621097
[TBL] [Abstract][Full Text] [Related]
71. The anti-cancer activity of Antrodia camphorata against human ovarian carcinoma (SKOV-3) cells via modulation of HER-2/neu signaling pathway.
Yang HL; Lin KY; Juan YC; Kumar KJ; Way TD; Shen PC; Chen SC; Hseu YC
J Ethnopharmacol; 2013 Jun; 148(1):254-65. PubMed ID: 23619020
[TBL] [Abstract][Full Text] [Related]
72. In vivo antitumor effects of 4,7-dimethoxy-5-methyl-1,3-benzodioxole isolated from the fruiting body of Antrodia camphorata through activation of the p53-mediated p27/Kip1 signaling pathway.
Tu SH; Wu CH; Chen LC; Huang CS; Chang HW; Chang CH; Lien HM; Ho YS
J Agric Food Chem; 2012 Apr; 60(14):3612-8. PubMed ID: 22429157
[TBL] [Abstract][Full Text] [Related]
73. Asparanin A induces G(2)/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Liu W; Huang XF; Qi Q; Dai QS; Yang L; Nie FF; Lu N; Gong DD; Kong LY; Guo QL
Biochem Biophys Res Commun; 2009 Apr; 381(4):700-5. PubMed ID: 19254688
[TBL] [Abstract][Full Text] [Related]
74. Comparison of the apoptotic effects of supercritical fluid extracts of Antrodia cinnamomea mycelia on hepatocellular carcinoma cells.
Lien HM; Chiu CH; Chen CC; Chang WL; Chyau CC; Peng RY
Molecules; 2014 Jun; 19(7):9033-50. PubMed ID: 24979405
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma.
Tam KH; Yang ZF; Lau CK; Lam CT; Pang RW; Poon RT
Cancer Lett; 2009 Jan; 273(2):201-9. PubMed ID: 18824293
[TBL] [Abstract][Full Text] [Related]
77.
Chen YC; Liu YC; El-Shazly M; Wu TY; Chang JG; Wu YC
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769922
[TBL] [Abstract][Full Text] [Related]
78. CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence.
da Silva EFG; Lima KG; Krause GC; Haute GV; Pedrazza L; Catarina AV; Gassen RB; de Souza Basso B; Dias HB; Luft C; Garcia MCR; Costa BP; Antunes GL; Basso LA; Donadio MVF; Machado P; de Oliveira JR
Invest New Drugs; 2020 Dec; 38(6):1653-1663. PubMed ID: 32367200
[TBL] [Abstract][Full Text] [Related]
79. Chemical investigations and cytotoxic effects of metabolites from
Chen YF; Wu HC; Chang JM; Ko HH; Lin CH; Chang HS
Nat Prod Res; 2023 Feb; 37(4):560-570. PubMed ID: 35583297
[No Abstract] [Full Text] [Related]
80. Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin.
Gambari R; Hau DK; Wong WY; Chui CH
Phytother Res; 2014 May; 28(5):781-3. PubMed ID: 23913631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
